NCT01978327 GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers Status TERMINATED Phase PHASE1
NCT01978301 Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid Scars Status TERMINATED Phase PHASE1
NCT01978236 Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites Status TERMINATED Phase PHASE2
NCT01978223 Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis Status WITHDRAWN Phase N/A
NCT01978145 A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01978119 A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol (FSC) 250/50 Microgram (mcg) Twice Daily (BID) in Adults and Adolescents With Asthma Status COMPLETED Phase PHASE3
NCT01978093 Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age Status COMPLETED Phase PHASE3
NCT01977573 A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD) Status COMPLETED Phase PHASE2
NCT01977482 Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia Status COMPLETED Phase PHASE2
NCT01974895 Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age Status COMPLETED Phase PHASE2
NCT01967771 Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT01966445 Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors Status COMPLETED Phase PHASE1
NCT01964924 Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT01962493 An Efficacy Study of Stain Control of a 67% Sodium Bicarbonate Containing Toothpaste on Chlorhexidine Tooth Staining Status COMPLETED Phase PHASE4
NCT01962467 A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine Status COMPLETED Phase PHASE1
NCT01962454 A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01957215 Efficacy of Topical Indomethacin Patch Over Placebo in Ankle Sprain Pain Relief Status COMPLETED Phase PHASE4
NCT01957202 A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR) Status COMPLETED Phase PHASE2
NCT01957189 This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples Status COMPLETED Phase PHASE1